Ignite Creation Date:
2024-05-05 @ 11:38 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00098098
Status:
COMPLETED
Last Update Posted:
2012-08-23
First Post:
2004-12-03
Brief Title:
Study to Evaluate the Safety Tolerability and Immunogenicity of Recombinant Botulinum Vaccine AB in Healthy Adults
Sponsor:
DynPort Vaccine Company LLC A GDIT Company
Organization:
DynPort Vaccine Company LLC A GDIT Company